The website and identity materials we designed are reflective of their great progress, and we hope their new brand serves them well.
Ann Arbor, MI (PRWEB) June 28, 2013
Hile Creative, LLC just completed a brand refresh — including the design and development of a new website — for Esperion Therapeutics, a Michigan-based biopharmaceutical company.
Esperion is a growing company focused on researching, developing, and commercializing new treatments for cardiovascular and metabolic diseases. Roger Newton, Esperion’s executive chairman and chief scientific officer, led the development of Pfizer’s Lipitor, a cholesterol-lowering drug classified as a statin. At Esperion, Newton and others are developing new, breakthrough treatments for patients who cannot tolerate statins.
To better align their image with the innovative nature of their work, the company approached Hile to develop a new look and feel for their brand. Hile designed a logo, business cards, stationery, presentation materials, and a new website, which launched June 26 — the day Esperion announced share prices for its initial public offering.
Dave Hile, president of Hile Creative, says, "It's exciting to be involved with the branding of a company that's making such important discoveries. With the announcement of its IPO, Esperion is moving into a new stage of growth and development. The website and identity materials we designed are reflective of their great progress, and we hope their new brand serves them well."
To view Esperion's website, visit http://www.esperion.com. Additional Hile Creative portfolio samples — including web design, print advertising, packaging, illustrations, case studies, and more — can be viewed at http://www.hilecreative.com/work.
Hile Creative is an Ann Arbor brand development and advertising agency that has been creatively serving businesses of all sizes for nearly 30 years. To learn more about Hile's full range of integrated services, visit http://www.hilecreative.com.